Zhang et al. [77] concluded that inhibition of androgen receptor (AR) in HCC could feedback to activate the AKT/mTOR signaling pathway, while mTOR reduced AR degradation and promoted the expression of nuclear AR protein. The gene discussed is AR; the disease is hepatocellular carcinoma.